Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.

Glycoprotein I ◽

Beta 2

Increased Fibrinogen Synthesis in Mice During the Acute Phase Response: Co-Operative Interaction of Interleukin 1, Interleukin 6, and Interleukin 1 Receptor Antagonist

10.21236/ada280464 ◽

1993 ◽

Author(s):

Hanna Rokita ◽

Ruta Neta ◽

Jean D. Sipe

Keyword(s):

Receptor Antagonist ◽

Acute Phase ◽

Interleukin 6 ◽

Acute Phase Response ◽

Interleukin 1 ◽

Phase Response ◽

Pre-interleukin-1α expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1)

Cytokine ◽

10.1016/j.cyto.2005.03.007 ◽

2005 ◽

Vol 31 (2) ◽

pp. 153-160 ◽

Cited By ~ 18

Author(s):

G PALMER ◽

S TROLLIET ◽

D TALABOTAYER ◽

F MEZIN ◽

D MAGNE ◽

...

Keyword(s):

Cell Growth ◽

Receptor Antagonist ◽

Interleukin 6 ◽

Interleukin 1 ◽

Inhibitory Effect ◽

Osteosarcoma Cells ◽

Interleukin 1Α

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting

The American Journal of Cardiology ◽

10.1016/s0002-9149(03)00327-8 ◽

2003 ◽

Vol 91 (11) ◽

pp. 1346-1349 ◽

Cited By ~ 20

Author(s):

Atul Aggarwal ◽

David J. Schneider ◽

Edward F. Terrien ◽

Christopher M. Terrien ◽

Burton E. Sobel ◽

...

Keyword(s):

Receptor Antagonist ◽

Interleukin 6 ◽

Interleukin 1 ◽

C Reactive Protein ◽

Reactive Protein ◽

Arterial Stenting

Increased fibrinogen synthesis in mice during the acute phase response: Cooperative interaction of interleukin 1, interleukin 6, and interleukin 1 receptor antagonist

Cytokine ◽

10.1016/1043-4666(93)90035-4 ◽

1993 ◽

Vol 5 (5) ◽

pp. 454-458 ◽

Cited By ~ 19

Author(s):

Hanna Rokita ◽

Ruta Neta ◽

Jean D. Sipe

Keyword(s):

Receptor Antagonist ◽

Acute Phase ◽

Interleukin 6 ◽

Acute Phase Response ◽

Interleukin 1 ◽

Phase Response ◽

Cooperative Interaction ◽

P-17 Serum Interleukin-6, glycoprotein 130, interleukin-1 receptor antagonist and ST2 as possible prognostic markers in head and neck squamous cell carcinoma (HNSCC)

Oral Oncology ◽

10.1016/s1368-8375(21)00306-7 ◽

2021 ◽

Vol 118 ◽

pp. 7

Author(s):

Helene Hersvik Aarstad ◽

Svein Erik Emblem Moe ◽

Oystein Bruserud ◽

Olav Karsten Vintermyr ◽

Stein Lybak ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Receptor Antagonist ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Interleukin 6 ◽

Prognostic Markers ◽

Interleukin 1 ◽

Neck Squamous Cell Carcinoma ◽

A pathway-based approach investigating the genes encoding interleukin-1 , interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy

British Journal of Sports Medicine ◽

10.1136/bjsm.2010.076760 ◽

2011 ◽

Vol 45 (13) ◽

pp. 1040-1047 ◽

Cited By ~ 26

Author(s):

A. V. September ◽

E.-M. Nell ◽

K. O'Connell ◽

J. Cook ◽

C. J. Handley ◽

...

Keyword(s):

Receptor Antagonist ◽

Genetic Susceptibility ◽

Interleukin 6 ◽

Interleukin 1 ◽

Achilles Tendinopathy ◽

Genes Encoding ◽

Insight Into

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

Annals of Neurology ◽

10.1002/ana.410370614 ◽

1995 ◽

Vol 37 (6) ◽

pp. 800-805 ◽

Cited By ~ 158

Author(s):

Nancy B. Beamer ◽

Bruce M. Coull ◽

Wayne M. Clark ◽

J. Samantha Hazel ◽

Jenny R. Silberger

Keyword(s):

Acute Stroke ◽

Receptor Antagonist ◽

Interleukin 6 ◽

Interleukin 1 ◽

Interleukin 6 (IL6), interleukin 6 soluble receptor (IL6sR), and interleukin 1 receptor antagonist (IL1ra) plasma concentrations in Crohn's disease

Gastroenterology ◽

10.1016/0016-5085(95)27635-1 ◽

1995 ◽

Vol 108 (4) ◽

pp. A832

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Receptor Antagonist ◽

Interleukin 6 ◽

Interleukin 1 ◽

Plasma Concentrations ◽

Soluble Receptor ◽

Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and postâtotal hip arthroplasty osteolysis

Arthritis & Rheumatism ◽

10.1002/art.25041 ◽

2009 ◽

Vol 60 (12) ◽

pp. 3856-3857 ◽

Cited By ~ 3

Author(s):

A. Gordon ◽

E. Kiss-Toth ◽

Ian Stockley ◽

Richard Eastell ◽

J. Mark Wilkinson

Keyword(s):

Total Hip Arthroplasty ◽

Receptor Antagonist ◽

Hip Arthroplasty ◽

Interleukin 6 ◽

Interleukin 1 ◽

Total Hip ◽

Association of interleukin-1 receptor antagonist and interleukin-6 polymorphisms with osteolysis after total hip arthroplasty: Comment on the article by Gordon et al

Arthritis & Rheumatism ◽

10.1002/art.24456 ◽

2009 ◽

Vol 60 (5) ◽

pp. 1563-1564 ◽

Cited By ~ 2

Author(s):

Jiri Gallo ◽

Martin Petrek

Keyword(s):

Total Hip Arthroplasty ◽

Receptor Antagonist ◽

Hip Arthroplasty ◽

Interleukin 6 ◽

Interleukin 1 ◽

Total Hip ◽